Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharm D Solutions was a Texas-based compounding pharmacy focused on preparing compounded drug products, including sterile compounded medicines distributed to clinics, physicians, consumers, and medical facilities. Public FDA records show the company conducted sterile compounding and retail pharmacy operations, but it became the subject of major regulatory enforcement related to insanitary conditions and sterility concerns. In September 2018, the company voluntarily recalled all sterile compounded drug products within expiry, and in May 2019 a federal consent decree required it to cease sterile compounding operations until corrective actions were completed and FDA authorization was obtained. Texas business-record aggregators list the legal entity as "forfeited existence," suggesting the company is no longer active as a legal operating entity. The business does not appear to be a drug developer, biotech platform company, or sponsor of a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharm D Solutions.